Skip to main content
Erschienen in: Journal of Neural Transmission 4/2017

08.12.2016 | Neurology and Preclinical Neurological Studies - Original Article

Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson’s disease

verfasst von: Jan Rusz, Tereza Tykalová, Radim Krupička, Kateřina Zárubová, Michal Novotný, Robert Jech, Zoltán Szabó, Evžen Růžička

Erschienen in: Journal of Neural Transmission | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

It is currently unknown whether speech and limb motor effectors in Parkinson’s disease (PD) are controlled by similar underlying brain processes. Based on computerized objective analysis, the aim of this study was to evaluate potential correlation between speech and mechanical tests of upper limb motor function. Speech and upper limb motor tests were performed in 22 PD patients and 22 healthy controls. Quantitative acoustic analyses of eight key speech dimensions of hypokinetic dysarthria, including quality of voice, sequential motion rates, consonant articulation, vowel articulation, average loudness, loudness variability, pitch variability, and number of pauses, were performed. Upper limb movements were assessed using the motor part of the Unified Parkinson’s Disease Rating Scale, contactless three-dimensional motion capture system, blinded expert evaluation, and the Purdue Pegboard Test. Significant relationships were observed between the quality of voice assessed by jitter and amplitude decrement of finger tapping (r = 0.61, p = 0.003), consonant articulation evaluated using voice onset time and expert rating of finger tapping (r = 0.60, p = 0.003), and number of pauses and Purdue Pegboard Test score (r = 0.60, p = 0.004). The current study supports the hypothesis that speech impairment in PD shares, at least partially, similar pathophysiological processes with limb motor dysfunction. Vocal fold vibration irregularities appeared to be influenced by mechanisms similar to amplitude decrement during repetitive limb movements. Consonant articulation deficits were associated with decreased manual dexterity and movement speed, likely reflecting fine motor control involvement in PD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Ackermann H, Ziegler W (1994) Acoustic analysis of vocal instability in cerebellar dysfunction. Ann Otol Rhinol Layngol 103:98–104CrossRef Ackermann H, Ziegler W (1994) Acoustic analysis of vocal instability in cerebellar dysfunction. Ann Otol Rhinol Layngol 103:98–104CrossRef
Zurück zum Zitat Baker KK, Ramig LO, Luschei ES, Smith ME (1998) Thyroarytenoid muscle activity associated with hypophonia in Parkinson’s disease and aging. Neurology 51:1592–1598CrossRefPubMed Baker KK, Ramig LO, Luschei ES, Smith ME (1998) Thyroarytenoid muscle activity associated with hypophonia in Parkinson’s disease and aging. Neurology 51:1592–1598CrossRefPubMed
Zurück zum Zitat Berardelli A, Rothwell JC, Thompson PD, Hallett M (2001) Pathophysiology of bradykinesia in Parkinson’s disease. Brain 124:2131–2146CrossRefPubMed Berardelli A, Rothwell JC, Thompson PD, Hallett M (2001) Pathophysiology of bradykinesia in Parkinson’s disease. Brain 124:2131–2146CrossRefPubMed
Zurück zum Zitat Blumin JH, Pcolinsky D, Atkins JP (2004) Laryngeal findings in advanced Parkinson’s disease. Ann Otol Rhinol Laryngol 113:253–258CrossRefPubMed Blumin JH, Pcolinsky D, Atkins JP (2004) Laryngeal findings in advanced Parkinson’s disease. Ann Otol Rhinol Laryngol 113:253–258CrossRefPubMed
Zurück zum Zitat Boersma P, Weenink D (2001) PRAAT, a system for doing phonetics by computer. Glot Int 5:341–345 Boersma P, Weenink D (2001) PRAAT, a system for doing phonetics by computer. Glot Int 5:341–345
Zurück zum Zitat Cantiniaux S, Vaugoyeau M, Robert D, Horrelou-Pitek C, Mancini J, Witjas T, Azulay JP (2010) Comparative analysis of gait and speech in Parkinson’s disease: hypokinetic or dysrhythmic disorders? J Neurol Neurosurg Psychiatry 81:177–184CrossRefPubMed Cantiniaux S, Vaugoyeau M, Robert D, Horrelou-Pitek C, Mancini J, Witjas T, Azulay JP (2010) Comparative analysis of gait and speech in Parkinson’s disease: hypokinetic or dysrhythmic disorders? J Neurol Neurosurg Psychiatry 81:177–184CrossRefPubMed
Zurück zum Zitat Defazio G, Guerrieri M, Liuzzi D, Gigante AF, di Nicola V (2016) Assessment of voice and speech symptoms in early Parkinson’s disease by the Robertson dysarthria profile. Neurol Sci 37:443–449CrossRefPubMed Defazio G, Guerrieri M, Liuzzi D, Gigante AF, di Nicola V (2016) Assessment of voice and speech symptoms in early Parkinson’s disease by the Robertson dysarthria profile. Neurol Sci 37:443–449CrossRefPubMed
Zurück zum Zitat Eichards M, Marder K, Cote L, Mayeux R (1994) Interrater reliability of the Unified Parkinson’s Disease Rating Scale motor examination. Mov Disord 9:89–91CrossRef Eichards M, Marder K, Cote L, Mayeux R (1994) Interrater reliability of the Unified Parkinson’s Disease Rating Scale motor examination. Mov Disord 9:89–91CrossRef
Zurück zum Zitat Goberman AM (2005) Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson disease. Med Sci Monit 11:109–116 Goberman AM (2005) Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson disease. Med Sci Monit 11:109–116
Zurück zum Zitat Goetz CG, Stebbins GT (2004) Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape. Mov Disord 19:1453–1456CrossRefPubMed Goetz CG, Stebbins GT (2004) Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape. Mov Disord 19:1453–1456CrossRefPubMed
Zurück zum Zitat Ho AK, Iansek R, Marigliani C, Bradshaw J, Gates S (1999) Speech impairment in large sample of patients with Parkinson’s disease. Behav Neurol 11:131–137CrossRefPubMed Ho AK, Iansek R, Marigliani C, Bradshaw J, Gates S (1999) Speech impairment in large sample of patients with Parkinson’s disease. Behav Neurol 11:131–137CrossRefPubMed
Zurück zum Zitat Ho AK, Bradshaw JL, Iansek R (2008) For better or worse: the effect of levodopa on speech in Parkinson’s disease. Mov Disord 23:575–580CrossRef Ho AK, Bradshaw JL, Iansek R (2008) For better or worse: the effect of levodopa on speech in Parkinson’s disease. Mov Disord 23:575–580CrossRef
Zurück zum Zitat Iansek R, Huxham F, McGinley J (2006) The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait? Mov Disord 21:1419–1424CrossRefPubMed Iansek R, Huxham F, McGinley J (2006) The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait? Mov Disord 21:1419–1424CrossRefPubMed
Zurück zum Zitat Krupicka R, Szabo Z, Viteckova S, Ruzicka E (2014) Motion capture system for finger movement measurement in parkinson disease. Radioeng 23:659–664 Krupicka R, Szabo Z, Viteckova S, Ruzicka E (2014) Motion capture system for finger movement measurement in parkinson disease. Radioeng 23:659–664
Zurück zum Zitat Ling H, Massey LA, Lees AJ, Brown P, Day BL (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135:1141–1153CrossRefPubMedPubMedCentral Ling H, Massey LA, Lees AJ, Brown P, Day BL (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135:1141–1153CrossRefPubMedPubMedCentral
Zurück zum Zitat Logemann JA, Fisher HB, Boshes B, Blonsky ER (1978) Frequency and cooccurrence of vocal tract dysfunction in the speech of a large sample of Parkinson patients. J Speech Hear Disord 43:47–57CrossRefPubMed Logemann JA, Fisher HB, Boshes B, Blonsky ER (1978) Frequency and cooccurrence of vocal tract dysfunction in the speech of a large sample of Parkinson patients. J Speech Hear Disord 43:47–57CrossRefPubMed
Zurück zum Zitat Maillet A, Krainik A, Debu B, Tropres I, Lagrange C, Thobois S, Pollak P, Pinto S (2012) Levodopa effects on hand and speech movements in patients with Parkinson’s disease: a FMRI study. PLoS One 7:e46541CrossRefPubMedPubMedCentral Maillet A, Krainik A, Debu B, Tropres I, Lagrange C, Thobois S, Pollak P, Pinto S (2012) Levodopa effects on hand and speech movements in patients with Parkinson’s disease: a FMRI study. PLoS One 7:e46541CrossRefPubMedPubMedCentral
Zurück zum Zitat Marsden CD (1989) Slowness of movement in Parkinson’s disease. Mov Disord Suppl 1:S26–S37CrossRef Marsden CD (1989) Slowness of movement in Parkinson’s disease. Mov Disord Suppl 1:S26–S37CrossRef
Zurück zum Zitat Martinez-Martin P, Forjaz MJ (2006) Metric attributes of the unified Parkinson’s disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precisions. Mov Disord 21:1182–1188CrossRefPubMed Martinez-Martin P, Forjaz MJ (2006) Metric attributes of the unified Parkinson’s disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precisions. Mov Disord 21:1182–1188CrossRefPubMed
Zurück zum Zitat Midi I, Dogan M, Koseoglu M, Can G, Sehitoglu MA, Gunal DI (2008) Voice abnormalities and their relation with motor dysfunction in Parkinson’s disease. Acta Neurol Scand 117:26–34PubMed Midi I, Dogan M, Koseoglu M, Can G, Sehitoglu MA, Gunal DI (2008) Voice abnormalities and their relation with motor dysfunction in Parkinson’s disease. Acta Neurol Scand 117:26–34PubMed
Zurück zum Zitat Moreau C, Ozsancak C, Blatt JL, Derambure P, Destee A, Defebvre L (2007) Oral festination in Parkinson’s disease: biomechanical analysis and correlation with festination and freezing of gait. Mov Disord 22:1503–1506CrossRefPubMed Moreau C, Ozsancak C, Blatt JL, Derambure P, Destee A, Defebvre L (2007) Oral festination in Parkinson’s disease: biomechanical analysis and correlation with festination and freezing of gait. Mov Disord 22:1503–1506CrossRefPubMed
Zurück zum Zitat Novotny M, Rusz J, Cmejla R, Ruzicka E (2014) Automatic evaluation of articulatory disorders in Parkinson’s disease. IEEE/ACM Trans Audio Speech Lang Process 22:1366–1378CrossRef Novotny M, Rusz J, Cmejla R, Ruzicka E (2014) Automatic evaluation of articulatory disorders in Parkinson’s disease. IEEE/ACM Trans Audio Speech Lang Process 22:1366–1378CrossRef
Zurück zum Zitat Park HK, Yoo JY, Kwon M, Lee JH, Lee SJ, Kim SR, Kim MJ, Lee MC, Lee SM, Chung SJ (2014) Gait freezing and speech disturbance in Parkinson’s disease. Neurol Sci 35:357–1336CrossRefPubMed Park HK, Yoo JY, Kwon M, Lee JH, Lee SJ, Kim SR, Kim MJ, Lee MC, Lee SM, Chung SJ (2014) Gait freezing and speech disturbance in Parkinson’s disease. Neurol Sci 35:357–1336CrossRefPubMed
Zurück zum Zitat Pinto S, Mancini L, Jahanshahi M, Thornston JS, Tripoliti E, Yousry TA, Limousin P (2011) Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson’s disease. Mov Disord 26:2212–2219CrossRefPubMedPubMedCentral Pinto S, Mancini L, Jahanshahi M, Thornston JS, Tripoliti E, Yousry TA, Limousin P (2011) Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson’s disease. Mov Disord 26:2212–2219CrossRefPubMedPubMedCentral
Zurück zum Zitat Rektorova I, Mekyska J, Janousova E, Kostalova M, Eliasova I, Mrackova M, Berankova D, Necasova T, Smekal Z, Marecek R (2016) Speech prosody impairment predicts cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord 29:90–95CrossRefPubMed Rektorova I, Mekyska J, Janousova E, Kostalova M, Eliasova I, Mrackova M, Berankova D, Necasova T, Smekal Z, Marecek R (2016) Speech prosody impairment predicts cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord 29:90–95CrossRefPubMed
Zurück zum Zitat Robertson LT, Hammerstadt JP (1996) Jaw movement dysfunction related to Parkinson’s disease and partially modified by levodopa. J Neurol Neurosurg Psyhiatry 60:41–50CrossRef Robertson LT, Hammerstadt JP (1996) Jaw movement dysfunction related to Parkinson’s disease and partially modified by levodopa. J Neurol Neurosurg Psyhiatry 60:41–50CrossRef
Zurück zum Zitat Roy N, Nissen SL, Dromey C, Sapir S (2009) Articulatory changes in muscle tension dysphonia: evidence for vowel space expansion following manual circumlaryngeal therapy. J Commun Disord 42:124–135CrossRefPubMed Roy N, Nissen SL, Dromey C, Sapir S (2009) Articulatory changes in muscle tension dysphonia: evidence for vowel space expansion following manual circumlaryngeal therapy. J Commun Disord 42:124–135CrossRefPubMed
Zurück zum Zitat Rusz J, Cmejla R, Ruzickova H, Ruzicka E (2011) Quantitative acoustic assessment of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am 129:350–367CrossRefPubMed Rusz J, Cmejla R, Ruzickova H, Ruzicka E (2011) Quantitative acoustic assessment of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am 129:350–367CrossRefPubMed
Zurück zum Zitat Rusz J, Cmejla R, Tykalova T, Ruzickova H, Klempir J, Majerova V, Picmausova J, Roth J, Ruzicka E (2013a) Imprecise vowel articulation as a potential early marker of Parkinson’s disease: Effect of speaking task. J Acoust Soc Am 134:2171–2181CrossRefPubMed Rusz J, Cmejla R, Tykalova T, Ruzickova H, Klempir J, Majerova V, Picmausova J, Roth J, Ruzicka E (2013a) Imprecise vowel articulation as a potential early marker of Parkinson’s disease: Effect of speaking task. J Acoust Soc Am 134:2171–2181CrossRefPubMed
Zurück zum Zitat Rusz J, Cmejla R, Ruzickova H, Klempir J, Majerova V, Picmausova J, Roth J, Ruzicka E (2013b) Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy. J Neural Transm 120:319–329CrossRefPubMed Rusz J, Cmejla R, Ruzickova H, Klempir J, Majerova V, Picmausova J, Roth J, Ruzicka E (2013b) Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy. J Neural Transm 120:319–329CrossRefPubMed
Zurück zum Zitat Rusz J, Tykalova T, Klempir J, Cmejla R, Ruzicka E (2016) Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients. J Neural Transm 123:379–387CrossRefPubMed Rusz J, Tykalova T, Klempir J, Cmejla R, Ruzicka E (2016) Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients. J Neural Transm 123:379–387CrossRefPubMed
Zurück zum Zitat Ruzicka E, Krupicka R, Zarubova K, Rusz J, Jech R, Szabo Z (2016) Tests of manual dexterity and speed in Parkinson’s disease: Not all measure the same. Parkinsonism Relat Disord 28:118–123CrossRefPubMed Ruzicka E, Krupicka R, Zarubova K, Rusz J, Jech R, Szabo Z (2016) Tests of manual dexterity and speed in Parkinson’s disease: Not all measure the same. Parkinsonism Relat Disord 28:118–123CrossRefPubMed
Zurück zum Zitat Sapir S (2014) Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J Speech Lang Hear Res 57:1330–1343CrossRefPubMed Sapir S (2014) Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J Speech Lang Hear Res 57:1330–1343CrossRefPubMed
Zurück zum Zitat Skodda S, Schlegel U (2008) Speech rate and rhythm in Parkinson’s disease. Mov Disord 23:985–992CrossRefPubMed Skodda S, Schlegel U (2008) Speech rate and rhythm in Parkinson’s disease. Mov Disord 23:985–992CrossRefPubMed
Zurück zum Zitat Skodda S, Wenke V, Schlegel U (2010) Short- and long-term dopaminergic effect on dysarthria in early Parkinson’s disease. J Neural Transm 117:2197–2205 Skodda S, Wenke V, Schlegel U (2010) Short- and long-term dopaminergic effect on dysarthria in early Parkinson’s disease. J Neural Transm 117:2197–2205
Zurück zum Zitat Skodda S, Visser W, Schlegel U (2011a) Gender related patterns of dysprosody in Parkinson’s disease and correlation between speech variables and motor symptoms. J Voice 25:76–82CrossRefPubMed Skodda S, Visser W, Schlegel U (2011a) Gender related patterns of dysprosody in Parkinson’s disease and correlation between speech variables and motor symptoms. J Voice 25:76–82CrossRefPubMed
Zurück zum Zitat Skodda S, Gronheit W, Schlegel U (2011b) Intonation and speech rate in Parkinson’s disease: general and dynamic aspects and responsiveness to levodopa admission. J Voice 25:e199–e205CrossRefPubMed Skodda S, Gronheit W, Schlegel U (2011b) Intonation and speech rate in Parkinson’s disease: general and dynamic aspects and responsiveness to levodopa admission. J Voice 25:e199–e205CrossRefPubMed
Zurück zum Zitat Skodda S, Flasskamp A, Schlegel U (2011c) Instability of syllable repetition in Parkinson’s disease—influence of levodopa and deep brain stimulation. Mov Disord 26:728–730CrossRefPubMed Skodda S, Flasskamp A, Schlegel U (2011c) Instability of syllable repetition in Parkinson’s disease—influence of levodopa and deep brain stimulation. Mov Disord 26:728–730CrossRefPubMed
Zurück zum Zitat Skodda S, Gronheit W, Schlegel U (2012) Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS One 7:e32132CrossRefPubMedPubMedCentral Skodda S, Gronheit W, Schlegel U (2012) Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS One 7:e32132CrossRefPubMedPubMedCentral
Zurück zum Zitat Yokoe M, Okuno R, Hamasaki T, Kurachi Y, Akazawa K, Sakoda S (2009) Opening velocity, a novel parameter, for finger tapping test in patients with Parkinson’s disease. Parkinsonism Relat Disord 15:440–444CrossRefPubMed Yokoe M, Okuno R, Hamasaki T, Kurachi Y, Akazawa K, Sakoda S (2009) Opening velocity, a novel parameter, for finger tapping test in patients with Parkinson’s disease. Parkinsonism Relat Disord 15:440–444CrossRefPubMed
Zurück zum Zitat Zarzur AR, Duprat G, Shinzato G, Eckley CA (2007) Laryngel electromyography in adults with Parkinson’s disease and voice complaints. Laryngoscope 117:831–834CrossRefPubMed Zarzur AR, Duprat G, Shinzato G, Eckley CA (2007) Laryngel electromyography in adults with Parkinson’s disease and voice complaints. Laryngoscope 117:831–834CrossRefPubMed
Metadaten
Titel
Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson’s disease
verfasst von
Jan Rusz
Tereza Tykalová
Radim Krupička
Kateřina Zárubová
Michal Novotný
Robert Jech
Zoltán Szabó
Evžen Růžička
Publikationsdatum
08.12.2016
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 4/2017
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-016-1662-y

Weitere Artikel der Ausgabe 4/2017

Journal of Neural Transmission 4/2017 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Original Article

Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism

Neurology and Preclinical Neurological Studies - Original Article

Safety of botulinum toxin short interval therapy using incobotulinumtoxin A

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.